PRGN-3007 UltraCAR-T Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PRGN-3007 UltraCAR-T Cells, covering 2026-02-06 to 2026-02-06. Get the full timeline:
Most recent: Clinical Trial Update: Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and Solid Tumor Malignancies [Phase 1]